EMA – Warning about sharp rise in illegal medicines sold in the EU
EMA and the Heads of Medicines Agencies (HMA) are warning the public about the growing threat of illegal medicines being advertised and sold online across the European Union (EU).
In recent months there has been a sharp rise in the number of illegal medicines marketed as GLP-1 receptor agonists such as semaglutide, liraglutide and tirzepatide for weight loss and diabetes. These products, often sold via fraudulent websites and promoted on social media, are not authorised and do not meet necessary standards of quality, safety and efficacy.
Such illegal products pose a serious risk to public health. They may not contain the claimed active substance at all and may contain harmful levels of other substances.
More information on the EMA Website.
OpenEdition vous propose de citer ce billet de la manière suivante :
vroby (22 novembre 2025). EMA – Warning about sharp rise in illegal medicines sold in the EU. ELSIBI. Consulté le 19 janvier 2026 à l’adresse https://doi.org/10.58079/156rl





